EM, erythema multiforme; BP, bullous pemphigoid; DEJ, dermal-epidermal
junction; DIF, direct immunofluorescence; C3, complement 3; SJS,
Stevens-Johnson syndrome.
Table 3. Summary of patient demographics, associated immunotherapy
class, rash characteristics, and other irAEs